The FDA has formally warned a number of firms to stop their illegal sales of unapproved, mislabeled version of the acne drug, Accutane (isotretinoin).
Recent Povorcitinib 2b Study Shows Improved Repigmentation
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Investigational LEO Pharma IL-22 Receptor Improves EASI Scores in AD
The Cutaneous Connection: JAK Inhibitor Safety for Treating AD
POLL: What Topics Did You Most Enjoy at AAD 2023?
Lanolin Named Allergen of the Year